Zynex Institutional ownership
What is the Institutional ownership of Zynex?
The Institutional ownership of Zynex, Inc. is 35.76%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on SZSE compared to Zynex
What does Zynex do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Companies with institutional ownership similar to Zynex
- Calamos Global Total Return Fund has Institutional ownership of 35.68%
- BlackRock MuniYield Quality Fund III Inc has Institutional ownership of 35.69%
- Lightpath Technologies has Institutional ownership of 35.70%
- Macquarie has Institutional ownership of 35.71%
- immatics biotechnologies GmbH has Institutional ownership of 35.73%
- Total SA has Institutional ownership of 35.75%
- Zynex has Institutional ownership of 35.76%
- Carbon Revolution has Institutional ownership of 35.78%
- Azul S.A has Institutional ownership of 35.78%
- Chemung has Institutional ownership of 35.78%
- Leifheit AG has Institutional ownership of 35.79%
- Spire has Institutional ownership of 35.80%
- STMicroelectronics N.V has Institutional ownership of 35.80%